City

Kuala Lumpur (1)

Tokyo (1)

Condition

Pediatric Hodgkin Lymphoma (2)

Pediatric Acute Lymphoid Leukemia (1)

Pediatric Acute Myeloid Leukemia (1)

Pediatric Non-Hodgkin Lymphoma (1)

Peripheral T Cell Lymphoma (1)

Overall Status

Active, not recruiting (1)

Not yet recruiting (1)

Sign in for free

Phase

n/a (1)

Sponsor

Takeda (1)

Universiti Kebangsaan Malaysia Medical Centre (1)

Collaborator

Ministry of Health, Malaysia (1)

Universiti Putra Malaysia (1)

Intervention

brentuximab vedotin (genetical recombination) (1)

ehope (1)

usual care (1)

Study Documents

Intervention Type

drug (1)

other (1)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (1)

Observational (1)

pediatric hodgkin lymphoma

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Brentuximab Vedotin Intravenous Infusion "Relapsed or Refractory

Active, not recruiting

Peripheral T Cell Lymphoma
Pediatric Hodgkin Lymphoma

Brentuximab Vedotin (Genetical Recombination)

Tokyo, Japan

Takeda Selected Site

Oct 11, 2022

Pediatric Acute Myeloid Leukemia, Pediatric Acute Lymphoid Leukemia, Pediatric Non-Hodgkin Lymphoma Trial in Kuala Lumpur

Not yet recruiting

Pediatric Acute Myeloid Leukemia
+3 more

eHOPE
Usual care

Kuala Lumpur, Malaysia
+1 more

Jul 7, 2022